Association between genetic polymorphism and adverse events or effectiveness of S-1-based chemotherapy in patients with gastrointestinal cancer
Not Applicable
- Conditions
- gastrointestinal cancer
- Registration Number
- JPRN-UMIN000001892
- Lead Sponsor
- Graduate School of Medicine, Kyoto University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients with at least 6 months S-1 free interval if they were re-treated by S-1-based chemotherapy (e.g. recurrence after adjuvant chemotherapy) 2. Patients who were judged ineligible by investigator
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Incidence of adverse events
- Secondary Outcome Measures
Name Time Method